HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9.

Abstract
We previously showed that the calcium-binding protein S100A4 is overexpressed during the progression of prostate cancer (CaP) in humans and in the TRAMP (transgenic adenocarcinoma of the mouse prostate) mouse model. We tested a hypothesis that the S100A4 gene plays a role in the invasiveness of human CaP and may be associated with its metastatic spread. We observed that siRNA-mediated suppression of the S100A4 gene significantly reduced the proliferative and invasive capability of the highly invasive CaP cells PC-3. We evaluated the mechanism through which the S100A4 gene controls invasiveness of cells by using a macroarray containing 96 well characterized metastatic genes. We found that matrix metalloproteinase 9 (MMP-9) and its tissue inhibitor (TIMP-1) were highly responsive to S100A4 gene suppression. Furthermore, S100A4 suppression significantly reduced the expression and proteolytic activity of MMP-9. By employing an MMP-9-promoter reporter, we observed a significant reduction in the transcriptional activation of the MMP-9 gene in S100A4-siRNA-transfected cells. Cells overexpressing the S100A4 gene (when transfected with pcDNA3.1-S100A4 plasmid) also significantly expressed MMP-9 and TIMP-1 genes with increased proteolytic activity of MMP-9 concomitant to increased transcriptional activation of the MMP-9 gene. S100A4-siRNA-transfected cells exhibited a reduced rate of tumor growth under in vivo conditions. Our data demonstrate that the S100A4 gene controls the invasive potential of human CaP cells through regulation of MMP-9 and that this association may contribute to metastasis of CaP cells. We suggest that S100A4 could be used as a biomarker for CaP progression and a novel therapeutic or chemopreventive target for human CaP treatment.
AuthorsMohammad Saleem, Mee-Hyang Kweon, Jeremy James Johnson, Vaqar Mustafa Adhami, Irina Elcheva, Naghma Khan, Bilal Bin Hafeez, Kumar M R Bhat, Sami Sarfaraz, Shannon Reagan-Shaw, Vladimir S Spiegelman, Vijayasaradhi Setaluri, Hasan Mukhtar
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 103 Issue 40 Pg. 14825-30 (Oct 03 2006) ISSN: 0027-8424 [Print] United States
PMID16990429 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • RNA, Messenger
  • RNA, Small Interfering
  • S100 Calcium-Binding Protein A4
  • S100 Proteins
  • Tissue Inhibitor of Metalloproteinase-1
  • S100A4 protein, human
  • Matrix Metalloproteinase 9
Topics
  • Animals
  • Gene Expression Regulation, Neoplastic
  • Genes, Neoplasm (genetics)
  • Humans
  • Male
  • Matrix Metalloproteinase 9 (genetics, metabolism)
  • Mice
  • Mice, Nude
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Neoplastic Stem Cells
  • Prostatic Neoplasms (genetics, pathology)
  • RNA, Messenger (genetics, metabolism)
  • RNA, Small Interfering (metabolism)
  • S100 Calcium-Binding Protein A4
  • S100 Proteins (genetics, metabolism)
  • Tissue Inhibitor of Metalloproteinase-1 (genetics, metabolism)
  • Transcription, Genetic
  • Transcriptional Activation (genetics)
  • Transfection
  • Transplantation, Heterologous
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: